Assistant Professor, Department of Nursing, Miami University, Hamilton, OH, USA.
Postdoctoral Fellow, Department of Anthropology, Miami University, Oxford, OH, USA.
J Nurs Scholarsh. 2021 Jan;53(1):55-64. doi: 10.1111/jnu.12609. Epub 2020 Nov 22.
The purpose was to summarize evidence of long-term outcomes of children, 2 years and older, exposed to opioids in-utero.
This was a systematic review. Studies were identified by searching the following electronic databases: PubMed, EBSCO HOST/Medline, and Web of Science. Articles were published between 1979 and 2019.
This systematic review was reported according to the Preferred Reporting Items for Systematic Review and Meta-Analysis. Two sets of two independent reviewers extracted data and assessed study quality according to National Institutes of Health quality assessment tools.
Forty-three articles met inclusion criteria. Synthesis of articles identified trends toward worse outcomes for children with in-utero opioid exposure in all areas, most notably related to academic success, behavior, cognition, hospitalizations, and vision.
Findings reinforce the necessity of continued research in this area with improved study design. Despite limitations in the current body of evidence, findings from this review are vital knowledge for clinicians, because children exposed to opioids in-utero are clearly vulnerable to a wide variety of suboptimal health and developmental outcomes.
Recognition of all outcomes across childhood associated with in-utero opioid exposure will inform improved identification and interventions tailored to the most pressing needs of affected children. Despite the need for continued research, there is sufficient evidence to necessitate close, individualized follow-up throughout childhood.
总结儿童在子宫内暴露于阿片类药物后 2 岁及以上的长期结局证据。
这是一项系统评价。通过检索以下电子数据库:PubMed、EBSCO HOST/Medline 和 Web of Science,来识别研究。文章发表于 1979 年至 2019 年期间。
本系统评价按照系统评价和荟萃分析的首选报告项目进行报告。两组两名独立的评审员根据美国国立卫生研究院的质量评估工具提取数据并评估研究质量。
43 篇文章符合纳入标准。文章综合分析表明,子宫内暴露于阿片类药物的儿童在所有领域的结局均较差,最明显的是与学业成功、行为、认知、住院和视力相关的结局。
这些发现强化了在该领域继续进行研究的必要性,需要改进研究设计。尽管当前证据存在局限性,但本综述的研究结果对于临床医生来说是至关重要的知识,因为子宫内暴露于阿片类药物的儿童显然容易受到各种健康和发育不良结局的影响。
认识到与子宫内阿片类药物暴露相关的所有儿童期结局,将有助于更好地识别和针对受影响儿童最紧迫的需求进行干预。尽管需要进一步研究,但现有证据足以证明需要在整个儿童期进行密切、个体化的随访。